Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 13/20 | 0.46 |
| ▸ | GAA | P10253 | 13/20 | 0.46 |
| ▸ | SI | P14410 | 13/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 13/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | CBFB | Q13951 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11786682 | 0.98 | HPSE (0.45) | HPSEMGAMGAASIMGAM2 | |
| Hydrochloric Acid SCHEMBL11789101 | 0.98 | HPSE (0.45) | HPSEMGAMGAASIMGAM2 | |
| SCHEMBL6985345 | 0.82 | CBFB (0.40) | HPSEKDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3413861 | 0.81 | HPSE (0.55) | HPSEMGAMGAASIMGAM2 | |
| Hydrochloric Acid SCHEMBL11784418 | 0.81 | EGLN1 (0.40) | HPSEKDM4ENPC1RAB9ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11576683 | 0.80 | HPSE (0.53) | HPSEMGAMGAASIMGAM2 | |
| SCHEMBL6984307 | 0.79 | MGAM (0.49) | HPSEMGAMGAASIMGAM2 | |
| SCHEMBL9419432 | 0.79 | MEN1 (0.36) | NPC1RAB9AHSD17B10ESR1 | |
| SCHEMBL6988487 | 0.78 | KDM4E (0.51) | KDM4EHPGDMAOBADORA2A | |
| SCHEMBL4900862 | 0.78 | ADORA2A (0.52) | HPSEMGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0920314-B1 | NON-PEPTIDE G-CSF MIMETICS | SMITHKLINE BEECHAM CORP (US) | 2003-08-27 | — | — | EP | disclosed |
| EP-1155014-B1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA AB (SE) | 2003-06-04 | — | — | EP | disclosed |
| US-6329383-B1 | THESE COMPOUNDS ARE USEFUL AS A HUMAN GROWTH HORMONE (HGH) MIMETIC, WHICH TRIGGER GH AGONIST EFFECTS IN ANIMALS AND ESPECIALLY AS AN ORALLY AVAILABLE HUMAN GROWTH HORMONE (HGH). | PHARMACIA AB (SE) | 2001-12-11 | — | — | US | disclosed |
| EP-1155014-A1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | Pharmacia AB (SE) | 2001-11-21 | — | — | EP | disclosed |
| EP-0920314-A4 | NON-PEPTIDE G-CSF MIMETICS | SMITHKLINE BEECHAM CORP (US) | 2001-08-16 | — | — | EP | disclosed |
| WO-2000043387-A1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA AB (SE) | 2000-07-27 | — | — | WO | disclosed |
| US-5981551-A | GRANULOCYTE COLONY-STIMULATING FACTOR MIMETICS; TREATMENT OF NEUTROPENIA | SMITHKLINE BEECHAM CORPORATION (US) | 1999-11-09 | — | — | US | disclosed |
| EP-0920314-A1 | NON-PEPTIDE G-CSF MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-06-09 | — | — | EP | disclosed |
| WO-1997044033-A1 | NON-PEPTIDE G-CSF MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-11-27 | — | — | WO | disclosed |
| US-3935314-A | Anti-hypertensive compositions of benzimidazole derivatives | BEECHAM GROUP LIMITED (EN) | 1976-01-27 | — | — | US | disclosed |